Redmile Group, based in California, backs life sciences and healthtech companies at Seed, Series A, and Series B, can lead rounds, and writes checks from $3 million to over $30 million.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckOne email when this firm shows new activity. Nothing else.
Redmile Group reports entry at seed, series a, series b.
Redmile Group reports checks of $3M to $30M+.
Yes. Redmile Group says it can lead.
No recent activity since September 2026.
Work at Redmile Group? Claim or correct this profile.